Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437082 · ClinicalTrials.gov registry record
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 143
- Enrollment target
NCT04437082: Completed study, sponsored by Optovue.
NCT04437082 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 143 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04437082 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 143 participants
- Enrollment target
Study Summary
The purpose of this study is to assess performance of measurements of anatomical and vascular structures of the eye based on OCT and OCTA scans in normal subjects and eyes with pathology.
Primary Outcome
measure of variance
Interventions
- DEVICE optical coherence tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2021-04-30 |
What the finished NCT04437082 record still lists
NCT04437082 is an observational study that tracks outcomes without assigning an intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which optical coherence tomography is the first listed.
NCT04437082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04437082 about?
NCT04437082 is a clinical study titled "Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)". The purpose of this study is to assess performance of measurements of anatomical and vascular structures of the eye based on OCT and OCTA scans in normal subjects and eyes with pathology.
What is the current status of trial NCT04437082?
This trial is currently completed. The enrollment target is 143 participants. The study started on 2021-01-15. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT04437082?
The interventions under investigation include: optical coherence tomography (DEVICE).
Who is sponsoring clinical trial NCT04437082?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI